Division of Pediatric Allergy–Immunology, Faculty of Medicine, University of Cukurova, Balcali, Adana, Turkey.
Ann Allergy Asthma Immunol. 2012 May;108(5):300-4. doi: 10.1016/j.anai.2012.02.019. Epub 2012 Mar 27.
Matrix metalloproteases (MMPs) are key mediators in airway remodeling, and MMP- 9 is the main type investigated to discover its implication for the pathogenesis and severity of asthma.
To evaluate MMP-9 and its natural tissue inhibitors of metalloproteinases (TIMP-1) levels of exhaled breath condensate (EBC) in children with asthma. We also analyzed any potential relationship between these enzymes and EBC interleukin (IL)-4/10 levels as well as asthma severity.
Three study groups were formed: group 1, children with persistent asthma (n = 20); group 2, children with intermittent asthma (n = 10), and group 3, healthy controls (n = 12). Pulmonary functions were measured as forced expiratory volume in 1 second (FEV(1)), peak expiratory flow (PEF), and forced expiratory flow from 25% to 75% of vital capacity values by spirometry, and MMP-9, TIMP-1 and IL-4/10 levels in EBC were analyzed by enzyme-linked immunosorbent assay (ELISA).
The MMP-9 levels of EBC were found to be 57.7 ± 17.5, 35.4 ± 11.7, and 30.6 ± 3.7 ng/mL in children belonging to group 1, group 2 and group 3, respectively. Children belonging to group 1 and group 2 showed significantly higher MMP-9 levels of EBC in comparison with the controls (P < .001 and P = .047, respectively). No statistically significant difference was found between groups regarding TIMP-1 levels of EBC. EBC MMP-9 levels were inversely correlated with both FEV(1) and PEF values (r = -0.472, P = .011, and r = -0.571, P = .002, respectively) in children with asthma. Positive correlations were also seen between MMP-9 levels and IL-4/10 levels of EBC (r = 0.419, P = .027 and r = 0.405, P = .032, respectively) in children with asthma.
We showed that MMP-9 levels of EBC are elevated in children with asthma and correlated with lung functions and other inflammatory markers such as IL-4/IL10 in EBC.
基质金属蛋白酶(MMPs)是气道重塑的关键介质,其中 MMP-9 是主要研究类型,以发现其对哮喘发病机制和严重程度的影响。
评估哮喘患儿呼出气冷凝液(EBC)中 MMP-9 及其天然金属蛋白酶组织抑制剂(TIMP-1)的水平。我们还分析了这些酶与 EBC 白细胞介素(IL)-4/10 水平以及哮喘严重程度之间的潜在关系。
形成三组研究对象:第 1 组,持续性哮喘患儿(n = 20);第 2 组,间歇性哮喘患儿(n = 10),第 3 组,健康对照组(n = 12)。通过肺量计测量第 1 秒用力呼气量(FEV1)、呼气峰流速(PEF)和用力呼出 25%至 75%肺活量时的流速值,通过酶联免疫吸附试验(ELISA)分析 EBC 中 MMP-9、TIMP-1 和 IL-4/10 水平。
第 1 组、第 2 组和第 3 组患儿 EBC 中的 MMP-9 水平分别为 57.7 ± 17.5、35.4 ± 11.7 和 30.6 ± 3.7 ng/mL。第 1 组和第 2 组患儿的 EBC 中 MMP-9 水平明显高于对照组(P <.001 和 P =.047)。EBC 中 TIMP-1 水平在各组间无统计学差异。哮喘患儿的 EBC MMP-9 水平与 FEV1 和 PEF 值呈负相关(r = -0.472,P =.011 和 r = -0.571,P =.002)。哮喘患儿 EBC 中 MMP-9 水平与 IL-4/10 水平呈正相关(r = 0.419,P =.027 和 r = 0.405,P =.032)。
我们发现哮喘患儿 EBC 中的 MMP-9 水平升高,并与肺功能以及 EBC 中的其他炎症标志物(如 IL-4/IL10)相关。